Marshall Wace LLP Invests $387,000 in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
Marshall Wace LLP purchased a new position in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 80,800 shares of the biopharmaceutical company’s stock, valued at approximately $387,000. Several other large investors have also recently […]
